Merz Therapeutics

As the International Association for the Study of Pain (IASP) 2026 World Congress on Pain approaches, we are excited to join the international pain community in Bangkok to discuss the latest advances in pain research. At this year’s congress, Merz Therapeutics will present new clinical and preclinical research in peripheral neuropathic pain, including findings from the Phase 2 PaiNT study and research exploring potential biological mechanisms involved in neuropathic pain. These contributions reflect our continued focus on advancing the science behind improved patient care and supporting evidence-based dialogues, with attention to functional goals and outcomes that matter in clinical practice. Join us on October 29 for scientific presentations, hands-on demonstrations and a Q&A session. We look forward to scientific exchanges with researchers and clinicians in-person! 📅 October 29, 2026 | 12:45–1:45 PM (Bangkok time) 📍 Grand Hall 202 Read more about our scientific contributions ahead of IASP 2026 here: https://lnkd.in/e63hjp6z #WC2026 #IASP #IASP2026

We are pleased to announce an important milestone for our #migraine clinical development program. Recruitment in two global Phase III trials has been completed six months ahead of schedule. Thank you to the patients, investigators and study teams who made this possible. 👉 Further information is available in our latest press release for investors and media. Read more here: https://lnkd.in/e7kwqjUD

One strategy. Many perspectives. One shared ambition. At the Global Strategic Forum in Vienna, our global leaders came together to connect, learn from one another and look ahead to what’s next. The result? A room full of engagement, fresh perspectives and, as Hale McKirnan, our Executive Director of Market Access in North America put it, “the right energy to take anything on." Watch our leaders share what #GSF2026 means to them and what they hope for in the future of Merz Therapeutics. #GlobalStrategicForum #Leadership #Collaboration #Growth

Earlier this month, colleagues from across Merz Therapeutics came together in Vienna for our Global Strategic Forum. Together, we explored the opportunities and challenges facing the specialty neurology industry, challenged our thinking and strengthened our shared vision for the future. Guided by our leadership team's vision, we're focused on building on our strengths, accelerating innovation and creating lasting value for the patients, caregivers and healthcare professionals we serve. The conversations started in Vienna will help shape the decisions we make tomorrow, and we're excited for what's ahead. #MerzTherapeutics #Leadership #NeurologyInnovation

Get the latest jobs and industry news

FY25/26 was a year of continued progress for Merz Therapeutics. From advancing clinical development and regulatory milestones to expanding partnerships and our global presence, we are continuing to build momentum in specialty neurology. These achievements reflect our commitment to scientific excellence, collaboration and, ultimately, improving outcomes for more patients: https://lnkd.in/e6RBncR5